Comparison of azelnidipine and trichlormethiazide in Japanese type 2 diabetic patients with hypertension: the COAT randomized controlled trial

Not Applicable

• Conditions: Type 2 diabetic patients with hypertension

• Registration Number: JPRN-UMIN000006081
• Lead Sponsor: Yokohama City Unuversity School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-07-30
• Study Completion: 2012-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with history of diabetic ketoacidosis, or diabetic coma within 6 months prior to the study entry. 2. Patients who received other antidiabetic within 3 months prior to the study entry. 3. Patients who received surgical operation during the study. 4. Patients with severe infection or severe trauma. 5. Patients with during pregnancy or lactation. 6. Patients with severe liver dysfunction. 7. Patients with severe renal dysfunction. 8. Patients who received insulin therapy. 9. Patients who received steroid therapy. 10. Patients with history of hypersensitivity reaction to azelnidipine or trichlormethiazide. 11. Patients determined to be inappropriate by physician.

Study & Design

• Study Type: Interventional
• Study Design: Not specified